In situ supported Pd NPs on biodegradable chitosan/agarose modified magnetic nanoparticles as an effective catalyst for the ultrasound assisted oxidation of alcohols and activities against human breast cancer

Targeted delivery of neratinib/xanthan gum-capped calcium carbonate nanoparticles induces apoptosis through PI3K/AKT pathway in breast cancer mice model

Breast cancer (BC) continues to be the most common malignancy among women, presenting therapeutic challenges including drug resistance. This study examines the effectiveness of neratinib-loaded xanthan gum-capped calcium carbonate nanoparticles (NB/XG@CaCO₃NPs) for targeted breast cancer treatment. The nanoparticles were synthesized using the co-precipitation method, characterized, and assessed against MCF7 and MDA-MB231 breast cancer cell lines. In vitro, NB/XG@CaCO₃NPs demonstrated considerable cytotoxicity at approximately 50 μg/mL, whereas non-cancerous HMEC cells retained high viability. Flow cytometry demonstrated an 85.2 % apoptosis rate, signifying effective cancer cell mortality. Mechanistic investigations validated that the downregulation of the PI3K/AKT pathway facilitated the anti-tumor effects. In vivo, NB/XG@CaCO₃NPs administered intravenously to cadmium chloride-induced breast cancer mice significantly diminished tumor volume and enhanced histomorphology without causing major organ toxicity. qRT-PCR and western blot analysis further confirmed tumor suppression at the molecular level. These results indicate that NB/XG@CaCO₃NPs present a viable targeted treatment for BC, efficiently suppressing tumor proliferation while maintaining biocompatibility.

Cydonia oblonga extract mediated biosynthesis of gold nanoparticles: Analysis of its anti-oral cancer and antioxidant properties

Here, using natural and biological macromolecules derived from Cydonia oblonga extract, we have developed a green protocol for the biogenic made Au NPs. Under ultrasonic activated conditions, the Cydonia oblonga phytomolecules were employed as an efficient green reducing agent for the Au3+ ions to the Au0 NPs. Additionally, by encapsulating or capping, they allowed the Au NPs to stabilize on their own. Several physicochemical techniques, such as elemental mapping, TEM, FE-SEM, UV-Vis spectroscopy, EDS, and ICP-OES, were used to analyze the structure of the Au NPs/Cydonia oblonga bio-nanocomposite. The field of medicinal therapeutics pertaining to human health includes cancer treatment as a major component. Subsequently, the as prepared Au NPs/Cydonia oblonga bio-nanocomposite was investigated for antioxidant and human anti-oral cancer assays. In such studies a number of cell lines, viz., HSC-3, HSC-2, and Ca9-22 were used in determining the cytotoxicity. Notably, Au NPs/Cydonia oblonga exhibit significant anti-oral cancer properties against HSC-3, HSC-2, and Ca9-22 cancer cell lines following time and dose-dependent manner. The corresponding IC50 values were determined as 201, 192, and 246 µg/mL respectively. DPPH radical scavenging method was used to determine the antioxidant activity of Au NPs/Cydonia oblonga bio-nanocomposite. The significant IC50 value suggested the material having very good antioxidant potential. The anti-human oral cancer effect of our material is believed to be due to its antioxidant effects.

Platinum Group Metals Nanoparticles in Breast Cancer Therapy

Despite various methods currently used in cancer therapy, breast cancer remains the leading cause of morbidity and mortality worldwide. Current therapeutics face limitations such as multidrug resistance, drug toxicity and off-target effects, poor drug bioavailability and biocompatibility, and inefficient drug delivery. Nanotechnology has emerged as a promising approach to cancer diagnosis, imaging, and therapy. Several preclinical studies have demonstrated that compounds and nanoparticles formulated from platinum group metals (PGMs) effectively treat breast cancer. PGMs are chemically stable, easy to functionalise, versatile, and tunable. They can target hypoxic microenvironments, catalyse the production of reactive oxygen species, and offer the potential for combination therapy. PGM nanoparticles can be incorporated with anticancer drugs to improve efficacy and can be attached to targeting moieties to enhance tumour-targeting efficiency. This review focuses on the therapeutic outcomes of platinum group metal nanoparticles (PGMNs) against various breast cancer cells and briefly discusses clinical trials of these nanoparticles in breast cancer treatment. It further illustrates the potential applications of PGMNs in breast cancer and presents opportunities for future PGM-based nanomaterial applications in combatting breast cancer.

Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery

Data published in 2020 by the International Agency for Research on Cancer (IARC) of the World Health Organization show that breast cancer (BC) has become the most common cancer globally, affecting more than 2 million women each year. The complex tumor microenvironment, drug resistance, metastasis, and poor prognosis constitute the primary challenges in the current diagnosis and treatment of BC. Magnetic iron oxide nanoparticles (MIONPs) have emerged as a promising nanoplatform for diagnostic tumor imaging as well as therapeutic drug-targeted delivery due to their unique physicochemical properties. The extensive surface engineering has given rise to multifunctionalized MIONPs. In this review, the latest advancements in surface modification strategies of MIONPs over the past five years are summarized and categorized as constrast agents and drug delivery platforms. Additionally, the remaining challenges and future prospects of MIONPs-based targeted delivery are discussed.

Fabrication of uniform Pd nanoparticles immobilized on crosslinked ionic chitosan support as a super-active catalyst toward regioselective synthesis of pyrazole-fused heterocycles

Selection of biodegradable chitosan as a raw material is a smart technique due to its easy modifiability and high renewability. Herein, taking advantage of these functional characteristics, an ionic biopolymer support is produced from copolymerization of allylated chitosan (with 48 % degree of substitution) and polymerizable ionic liquid ([MEVIm]Br). Next, palladium nanoparticles are successfully stabilized in this designed support through a facile manner based on interconnected porous network, ionic nature and rich functional groups. Then, the Pd@CS-PIL structure was utilized as a heterogeneous catalyst for regioselective synthesis of pyrazole-fused heterocycles. The as-synthesized Pd@CS-PIL was characterized by various techniques such as XRD, EDX, FESEM, elemental mapping, TEM, BET, ICP, TGA, and FT-IR to better determine the structure, morphology, purity and physical properties. The obtained results revealed that the proposed nanostructure provides favorable porosity with significant specific surface area (139.2 m2.g-1), Pd nanoparticles with high dispersion (mean diameter ∼ 22.8 nm) and crosslinked nature with good thermal stability (50 % weight loss about 600 °C). Therefore, Pd@CS-PIL nanostructure showed the key features of a super-active catalyst, and pharmaceutical pyrazole-fused scaffolds were produced in favorable yields (86-96 %) under ultrasound conditions.

Fabrication of silver nanoparticles immobilized on magnetic lignosulfonate: Evaluation of its catalytic activity in the N-acetylation reactions and investigation of its anti-cutaneous squamous cell carcinoma effects

Due to the non-optimal response of most types of cancer to various treatment methods and their rapid progress, research continues in the field of producing drugs with less toxicity and greater efficiency. There are many nanocomposites with diverse biological activities that include part of anticancer drugs in new pharmacological science. The present investigation describes a green procedure for the in situ support of Ag nanoparticles (NPs) over sodium lignosulfonate (NaLS) modified magnetic nanoparticles (Fe3O4@NaLS/Ag) and its subsequent biological and chemical performance. FT-IR, TEM, FE-SEM, EDS, ICP, VSM and XRD techniques were used to characterize the synthesized Fe3O4@NaLS/Ag. The catalytic efficacy of the desired composite was applied in the N-acetylation of various amines in the presence of Ac2O under solvent-free conditions. The Fe3O4@NaLS/Ag catalyst was recovered by an external magnet and reused for nine runs without a significant decrease in the activity. The cytotoxic and anti-cutaneous squamous cell carcinoma potentials of biologically synthesized Fe3O4@NaLS/Ag nanocomposite against PM1 and MET1 cells were determined. The anti-cutaneous squamous cell carcinoma properties of the Fe3O4@NaLS/Ag nanocomposite could significantly remove PM1 and MET1 cells. The IC50 of Fe3O4@NaLS/Ag nanocomposite was 288 and 270 μg/mL against PM1 and MET1 cells, respectively. Also, Fe3O4@NaLS/Ag nanocomposite presented a high antioxidant potential according to the IC50 value. According to the above results, the recent nanocomposite can be used in treating cutaneous squamous cell carcinoma after doing clinical trial studies.

Microwave-Assisted Synthesis of Pd Nanoparticles into Wood Block (Pd@wood) as Efficient Catalyst for 4-Nitrophenol and Cr(VI) Reduction

Palladium (Pd) nanoparticle catalysis has attracted increasing attention due to its efficient catalytic activity and its wide application in environmental protection and chemical synthesis. In this work, Pd nanoparticles (about 71 nm) were synthesized in aqueous solution by microwave-assisted thermal synthesis and immobilized in beech wood blocks as Pd@wood catalysts. The wood blocks were first hydrothermally treated with 10% NaOH solution to improve the internal structure and increase their porosity, thereby providing favorable attachment sites for the formed Pd nanoparticles. The stable deposition of Pd nanoparticle clusters on the internal channels of the wood blocks can be clearly observed. In addition, the catalytic performance of the prepared Pd@wood was investigated through two model reactions: the reduction of 4-nitrophenol and Cr(VI). The Pd@wood catalyst showed 95.4 g-1 s-1 M-1 of normalized rate constant knorm and 2.03 min-1 of the TOF, respectively. Furthermore, Pd nanoparticles are integrated into the internal structure of wood blocks by microwave-assisted thermal synthesis, which is an effective method for wood functionalization. It benefits metal nanoparticle catalysis in the synthesis of fine chemicals as well as in industrial wastewater treatment.

Carbohydrate polymer-based nanocomposites for breast cancer treatment

Breast cancer is known as the most common invasive malignancy in women with the highest mortality rate worldwide. This concerning disease may be presented in situ (relatively easier treatment) or be invasive, especially invasive ductal carcinoma which is highly worrisome nowadays. Among several strategies used in breast cancer treatment, nanotechnology-based targeted therapy is currently being investigated, as it depicts advanced technological features able of preventing drugs' side effects on normal cells while effectively acting on tumor cells. In this context, carbohydrate polymer-based nanocomposites have gained particular interest among the biomedical community for breast cancer therapy applications due to their advantage features, including abundance in nature, biocompatibility, straightforward fabrication methods, and good physicochemical properties. In this review, the physicochemical properties and biological activities of carbohydrate polymers and their derivate nanocomposites were discussed. Then, various methods for the fabrication of carbohydrate polymer-based nanocomposites as well as their application in breast cancer therapy and future perspectives were discussed.

Design and synthesis of Ag NPs/chitosan-starch nano-biocomposite as a modern anti-human malignant melanoma drug

In recent years, the unprecedented increase in various cancers such as melanoma has caused researchers to focus more on the formulation of newer drugs with less side effects. In this study, we herein indicate the biogenic nanoarchitechtonics of Ag NPs template over chitosan/starch mixed hydrogel having notable reducing potential and anti-malignant melanoma effects. The two biopolymers also could stabilize as-synthesized Ag NPs. Physicochemical features of the material were further characterized over a range of advanced methods like X-ray diffraction (XRD), elemental mapping, dynamic light scattering (DLS), energy-dispersive X-ray spectroscopy (EDS), transmission electron microscopy (TEM), field emission scanning electron microscopy (FESEM), and Fourier transformed infrared spectroscopy (FT-IR). TEM analysis showed the spherical-shaped nanocomposite with the mean diameter in the range of 5-15 nm. Thereafter, the nanocomposite was exploited in the anti-malignant melanoma and cytotoxicity effects studies against various human malignant melanoma cell lines (HT144, RPMI7951, SKMEL2, UACC3074, WM266-4 and MUM2C) in situ. The bio-composite corresponding IC₅₀ values were 193, 102, 227, 250, 301, and 203 μg/mL against MUM2C, WM266-4, UACC3074, SKMEL2, RPMI7951, and HT144 cell lines, respectively. A significantly high IC₅₀ value offered an excellent antioxidant capacity of bio-composite. According to the above results, Ag NPs/CS-Starch nanomaterial can be utilized as an efficient drug to treat malignant melanoma in humans after doing clinical trial studies.

A convenient green protocol for oxidative esterification of arylaldehydes over Pd NPs decorated polyplex encapsulated Fe3O4 microspheres

A mild, competent and eco-friendly protocol has been developed for oxidative esterification of various aldehydes over a post-synthetically modified and Pd fabricated chitosan-starch dual functionalized Fe3O4 microspheres as a magnetically isolable heterogeneous and biocompatible nanocatalyst. Molecular O2 was used as an oxidant in the reaction. A series of aldehydes was directly esterified with MeOH in excellent yields without any pre-activation and involvement of harsh chemicals/conditions. Structural features of the catalyst were assessed through FT-IR, FE-SEM, TEM, EDX, molecular mapping, XRD, VSM and ICP-OES techniques. Due to magnetic core, the catalyst was easily isolated using an external magnet and reused for 8 times in succession, retaining its morphology and catalytic activity.

Functionalized hybrid magnetic catalytic systems on micro- and nanoscale utilized in organic synthesis and degradation of dyes

Herein, a concise review of the latest developments in catalytic processes involving organic reactions is presented, focusing on magnetic catalytic systems (MCSs). In recent years, various micro- and nanoscale magnetic catalysts have been prepared through different methods based on optimized reaction conditions and utilized in complex organic synthesis or degradation reactions of pharmaceutical compounds. These biodegradable, biocompatible and eco-benign MCSs have achieved the principles of green chemistry, and thus their usage is highly advocated. In addition, MCSs can shorten the reaction time, effectively accelerate reactions, and significantly upgrade both pharmaceutical synthesis and degradation mechanisms by preventing unwanted side reactions. Moreover, the other significant benefits of MCSs include their convenient magnetic separation, high stability and reusability, inexpensive raw materials, facile preparation routes, and surface functionalization. In this review, our aim is to present at the recent improvements in the structure of versatile MCSs and their characteristics, i.e., magnetization, recyclability, structural stability, turnover number (TON), and turnover frequency (TOF). Concisely, different hybrid and multifunctional MCSs are discussed. Additionally, the applications of MCSs for the synthesis of different pharmaceutical ingredients and degradation of organic wastewater contaminants such as toxic dyes and drugs are demonstrated.

Chitosan: A versatile bio-platform for breast cancer theranostics

Breast cancer is considered one of the utmost neoplastic diseases globally, with a high death rate of patients. Over the last decades, many approaches have been studied to early diagnose and treat it, such as chemotherapy, hormone therapy, immunotherapy, and MRI and biomarker tests; do not show the optimal efficacy. These existing approaches are accompanied by severe side effects, thus recognizing these challenges, a great effort has been done to find out the new remedies for breast cancer. Main finding: Nanotechnology opened a new horizon to the treatment of breast cancer. Many nanoparticulate platforms for the diagnosis of involved biomarkers and delivering antineoplastic drugs are under either clinical trials or just approved by the Food and Drug Administration (FDA). It is well known that natural phytochemicals are successfully useful to treat breast cancer because these natural compounds are safer, available, cheaper, and have less toxic effects. Chitosan is a biocompatible and biodegradable polymer. Further, it has outstanding features, like chemical functional groups that can easily modify our interest with an exceptional choice of promising applications. Abundant studies were directed to assess the chitosan derivative-based nanoformulation's abilities in delivering varieties of drugs. However, the role of chitosan in diagnostics and theranostics not be obligated. The present servey will discuss the application of chitosan as an anticancer drug carrier such as tamoxifen, doxorubicin, paclitaxel, docetaxel, etc. and also, its role as a theranostics (i.e. photo-responsive and thermo-responsive) moieties. The therapeutic and theranostic potential of chitosan in cancer is promising and it seems that to have a good potential to get to the clinic.

Chitosan-starch biopolymer modified kaolin supported Pd nanoparticles for the oxidative esterification of aryl aldehydes

A mild and efficient green protocol has been disclosed for selective oxidative esterification of various aldehydes over a novel Pd fabricated chitosan-starch polyplex encapsulated Kaolin (Kaolin@CS-starch-Pd) as a heterogeneous and reusable biocompatible nanocatalyst. Molecular oxygen was used as an oxidizing agent to generate water as the sole by-product. A wide variety of aldehydes was converted to their methyl esters in high yields. The process involved gentle reaction conditions to avoid any type of pre-activation. Structural features of the catalyst were determined through FT-IR, FE-SEM, TEM, EDX, elemental mapping, XRD and ICP-OES analyses. The material was found to be stable enough toward Pd leaching. Durability of Kaolin@CS-starch-Pd was further justified by retaining its catalytic activity through successful reusability for several times.

Magnetic nanoparticles for cancer theranostics: Advances and prospects

Cancer is one of the leading causes of mortality worldwide. Nanoparticles have been broadly studied and emerged as a novel approach in diagnosis and treatment of tumors. Over the last decade, researches have significantly improved magnetic nanoparticle (MNP)'s theranostic potential as nanomedicine for cancer. Newer MNPs have various advantages such as wider operating temperatures, smaller sizes, lower toxicity, simpler preparations and lower production costs. With a series of unique and superior physical and chemical properties, MNPs have great potential in medical applications. In particular, using MNPs as probes for medical imaging and carriers for targeted drug delivery systems. While MNPs are expected to be the future of cancer diagnosis and precision drug delivery, more research is still required to minimize their toxicity and improve their efficacy. An ideal MNP for clinical applications should be precisely engineered to be stable to act as tracers or deliver drugs to the targeted sites, release drug components only at the targeted sites and have minimal health risks. Our review aims to consolidate the recent improvements in MNPs for clinical applications as well as discuss the future research prospects and potential of MNPs in cancer theranostics.

Nanopharmaceutical-based regenerative medicine: a promising therapeutic strategy for spinal cord injury

Spinal cord injury (SCI) is a neurological disorder that can lead to loss of perceptive and athletic function due to the severe nerve damage. To date, pieces of evidence detailing the precise pathological mechanisms in SCI are still unclear. Therefore, drug therapy cannot effectively alleviate the SCI symptoms and faces the limitations of systemic administration with large side effects. Thus, the development of SCI treatment strategies is urgent and valuable. Due to the application of nanotechnology in pharmaceutical research, nanopharmaceutical-based regenerative medicine will bring colossal development space for clinical medicine. These nanopharmaceuticals (i.e. nanocrystalline drugs and nanocarrier drugs) are designed using different types of materials or bioactive molecules, so as to improve the therapeutic effects, reduce side effects, and subtly deliver drugs, etc. Currently, an increasing number of nanopharmaceutical products have been approved by drug regulatory agencies, which has also prompted more researchers to focus on the potential treatment strategies of SCI. Therefore, the purpose of this review is to summarize and elaborate the research progress as well as the challenges and future of nanopharmaceuticals in the treatment of SCI, aiming to promote further research of nanopharmaceuticals in SCI.